Hythiam (HYTM) Reports Q2 Loss of $0.26
More News related to HYTM
- Research Provides Further Evidence for the Mechanism of Action Underlying Hythiam's PROMETA(R) Treatment Program
- Greg McLane Joins Hythiam as Senior Vice President, Sales and Marketing
- Hythiam (HYTM) Reports In-Line Q3 Loss of $0.13
- Hythiam Announces Third Quarter Results
- Hythiam to Present at Rodman & Renshaw's 10th Annual Healthcare Conference
More News related to Earnings
- Raymond James Starts Millicom (MICC) at Strong Buy
- Stifel Nicolaus Starts City National (CYN) at Hold
- Stifel Nicolaus Starts eHealth (Nasdaq: HLTH) with a Buy
- Wasserman & Associates initiates coverage on American Physicians Service Group (AMPH) with a Buy
- Jesup & Lamont Initiates Coverage on AutoZone (AZO) with a Hold.
Hythiam, Inc. (Nasdaq: HYTM) reports a Q2 loss of $0.26, 9 cents lower than the analyst estimate of ($0.17). Revenues for the quarter were $11.6 million, versus the consensus of $11.93 million.
Hythiam, Inc., a healthcare services management company, provides behavioral health management services to health plans, employers, criminal justice, and government agencies.
Related Categories
EarningsStocks Mentioned
+0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
